Deviations in the gut microbiota of neonates affected by maternal group B Streptococcus colonization

Yue-Feng Li1, Xue-Lei Gong1, Su-Xiang Chen1

  • 1Department of Pediatrics, Shenzhen Luohu Maternity and Child Health Hospital, Shenzhen, 518019, China.

BMC Microbiology
|May 6, 2021
PubMed

Insights

Group B Streptococcus (GBS) colonization in newborns is linked to gut microbiota changes. Reduced Lactobacillus paracasei abundance suggests a role in GBS colonization, impacting infant health.

Area of Science:

  • Microbiology
  • Neonatal Health
  • Gut Microbiome Research

Background:

  • Group B Streptococcus (GBS) is a primary cause of neonatal infections like septicemia, meningitis, and pneumonia.
  • Early-life gut dysbiosis is associated with later-life diseases.
  • The relationship between gut microbial alterations and GBS colonization remains poorly understood.

Purpose of the Study:

  • To investigate the associations between gut microbial composition and GBS colonization in neonates.
  • To identify specific microbial taxa that differ between GBS-colonized and non-colonized infants.

Main Methods:

  • Analysis of meconium microbiota composition and diversity.
  • Utilized linear discriminant analysis (LDA) effect size (LEfSe) to identify differentially abundant taxa.
  • Compared microbiota between neonates with and without GBS colonization.

Main Results:

  • Meconium microbiota composition and diversity were similar between GBS and control groups.
  • Identified specific differentially abundant taxa between the groups (LDA effect size, p < 0.05, LDA > 2.0).
  • Significantly reduced relative abundance of Lactobacillus paracasei was observed in GBS-colonized neonates.

Conclusions:

  • The study provides evidence of initial intestinal microbiota dysbiosis in neonates with maternal GBS colonization.
  • Identified specific bacterial species associated with GBS colonization.
  • Suggests a potential role for Lactobacillus paracasei in GBS colonization.
Abstract